Barriers and Facilitators to medication compliance in IBD patients
Details of Research
Contact: Jhananiee Subendran, Research Student
416-586-4800 ext 2159
Primary Investigator: Erin Kennedy, MD
Objective: The main aim of this study is to explore the perspectives of individuals with IBD in Toronto, Canada on barriers and facilitators to the compliance of medication.
Expectation: This research may lead to a better understanding of lower compliance rates, and suggest possible ways to improve rates.
Eligibility: Anyone over 18 years diagnosed with IBD (Crohn’s Disease, Ulcerative Colitis or Indeterminate Colitis), have been on any type of treatment for at least 2 years, and are currently on an immunomodulator (Methotrexate) or biologic (Remicade/Humira/etc).
Participation: Participation involves a one-time interview ~30 minutes with the coordinator. Refreshments will be provided.
We would like to thank you in advance for your interest and continued support.
Please contact Jhananiee Subendran (email email@example.com) if you are interested in participating in this study.